DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Q&A with Michael Darling, VP Supply Chain, St. Luke’s Health System Discussing the clinical integration of supply chain

Consolidation, consumerism and telehealth are the top three industry trends for 2019 According to a wide sampling of 1,000 healthcare stakeholders

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

M&A trend lines in tech-enabled medical devices Connecting the dots on industry consolidation

Siemens' push to install Atellica systems may hurt full-year profits Still, Q2 growth 'clearly accelerated'

Radiology Partners and Banner Health team up to establish Banner Imaging Provides imaging services throughout the metro Phoenix area

M&A checklist: Get the most out of your time Buyer and seller trends for mergers and acquisitions

Air medical transportation: How a 15-minute ride may cost $30,000, and how we can change it Reducing sky-high transport expenses

Canon's Vital Images wins DoD contract Maximum $100 million fixed‐price contract for radiology and imaging systems

Are you GDPR compliant? It's not just a question for EU-based companies Here are the top eight considerations

GE Healthcare IPO on hold as new deal takes spotlight

par Thomas Dworetzky , Contributing Reporter
GE chairman and CEO Larry Culp has said that in light of its just-announced deal with Danaher, the IPO for its healthcare division might be on hold.

“An IPO [for GE's healthcare unit] in 2019 looks unlikely at this point,” Culp told CNBC.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



That's due to its present focus on the sale of the GE Life Sciences unit to Danaher, where it will become a standalone business combined with Danaher's Life Science, according to CNBC.

That deal is worth $21.4 billion – $21 billion in cash and the assumption of some GE pension costs. That's good news for Wall Street; as of year-end 2018, pensions accounted for $21 billion of the company's $55 billion in industrial debt, CNBC reported.

But some reports that the healthcare IPO is not ever going to happen are erroneous, the news station advised.

Instead, it is just delayed because, Culp told CNBC's Morgan Brennan, “we are focused on completing the [Danaher] carve out – which is 15 percent of the $20 billion healthcare segment – and focused on managing the remaining core business.”

Despite the interest in doing a health unit IPO in order to let GE focus on its core businesses, the interest in the biopharma unit presented too good an opportunity to miss.

“IPO of healthcare was Plan A, but we got lots of inbound calls about this business and this is clearly a superior path,” Culp told CNBC’s David Faber.

The Danaher deal is a big help for GE's debt-cutting efforts, with CNBC stating that Cowen Research said in a note that the deal offered “a rich valuation that goes a long way toward GE’s debt reduction.”

Credit Suisse also weighed in, calling the sale of biopharma “a positive” and adding that, “under CEO Culp, GE has been accelerating its strategy to strengthen and deleverage the balance sheet.”

Culp sat atop Danaher as CEO and president from 2000 to 2014, joining the GE board in April, 2018, and becoming GE Chairman and CEO when he replaced John Flannery in October, 2018. In April, 2018, Danaher expressed interest it taking the GE Life Sciences unit, said CNBC, citing the Wall Street Journal.

In January, Culp was touting the healthcare unit sale in a post-earnings conference call after GE's above-expectations Q4 revenue was revealed on the call, when he stated, “we expect to monetize just up to under 50 percent of our healthcare business,” adding that the unit “continues to prepare for public company separation, and that is progressing very well," according to CNBC.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS